Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for blood cancer patients: experimental drug combo enters human testing

NCT ID NCT06768489

Recruiting now Disease control Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing a new drug called JNJ-79635322 when combined with existing multiple myeloma treatments. Researchers aim to find safe and effective doses for 140 participants with different treatment histories. The trial will closely monitor side effects and how well the combinations work against the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Calvary Mater Newcastle Hospital

    RECRUITING

    Waratah, 2298, Australia

  • Carmel Medical Center

    RECRUITING

    Haifa, 3436212, Israel

  • Hadassah Medical Center

    RECRUITING

    Jerusalem, 9112001, Israel

  • Hosp Clinico Univ de Salamanca

    RECRUITING

    Salamanca, 37007, Spain

  • Hosp. Clinic de Barcelona

    RECRUITING

    Barcelona, 08036, Spain

  • Monash Medical Centre

    RECRUITING

    Clayton, 3168, Australia

  • Peter MacCallum Cancer Centre

    RECRUITING

    Melbourne, 3000, Australia

  • Sheba Medical Center

    RECRUITING

    Ramat Gan, 52621, Israel

  • St Vincents Hospital Melbourne

    RECRUITING

    Fitzroy, 3065, Australia

  • Tel Aviv Sourasky Medical Center

    RECRUITING

    Tel Aviv, 64239, Israel

  • UMC Utrecht

    RECRUITING

    Utrecht, 3584 CX, Netherlands

  • Universitair Medisch Centrum Groningen

    RECRUITING

    Groningen, 9713 GZ, Netherlands

  • VU Medisch Centrum

    RECRUITING

    Amsterdam, 1081 HV, Netherlands

  • Wollongong Hospital

    RECRUITING

    Wollongong, 2500, Australia

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA